Table 2. Clinical characteristics of the 11 melanoma patients.
No. | Sex | Age (years) | Histopathological type | AJCC stage | Metastatic sites | No. of CTC in 5 ml of PB |
---|---|---|---|---|---|---|
1 | M | 54 | Mucosal | IV | Lymph nodes, lung, brain, spinal cord | 2–5 |
2 | F | 78 | Mucosal | IV | Lymph nodes, lung, liver | 2 |
3 | M | 67 | Mucosal | IIIC | Lymph nodes | 5 |
4 | F | 68 | Mucosal | IV | Lymph nodes, lung | 1–5 |
5 | F | 64 | Non-CSD | IV | Lymph nodes, lung, liver, skin | 1–20 |
6 | M | 61 | Non-CSD | IV | Lymph nodes, lung, brain, skin | 2–7 |
7 | F | 62 | Non-CSD | IV | Lymph nodes, lung, peritoneum | 1–3 |
8 | M | 73 | Non-CSD | IV | Lymph nodes, digestive tract, pleura, abdominal cavity, skin | 1 |
9 | M | 69 | Unknown | IV | Lymph nodes, liver, digestive tract, bone, adrenal, skin | 8 |
10 | F | 62 | Acral | IIIC | Lymph nodes | 6 |
11 | M | 84 | Acral | IV | Lymph nodes, lung, brain | 7 |
Abbreviations: CTC=circulating tumour cells; non-CSD=melanoma on non-chronic sun-damaged skin; PB=peripheral blood.